In addition to its role asa tumour suppressor, reduced expression of FH has been implicated in hypertension,27 type 2 diabetes28 and diabetic kidney disease.29 In mice, FH has been identified as a key regulator of metabolism inhaematopoietic stem cells and deficiency is associated with aberrant lymphoid differentiation.30 The gene discussed is FH; the disease is neoplasm.